536 results on '"Yost, Kathleen J"'
Search Results
2. ASO Visual Abstract: Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective Trial
3. PRO-Angoff method for remote standard setting: establishing clinical thresholds for the upper digestive disease tool
4. Development and acceptability of PETS-Now, an electronic point-of-care tool to monitor treatment burden in patients with multiple chronic conditions: a multi-method study
5. Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
6. Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
7. Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks
8. Patients Struggle With Severe Symptoms Even After Surviving Esophagectomy for Esophageal Cancer
9. Agreement Between Upper Digestive Disease App and Provider Evaluation of Esophagectomy Symptoms in a Mobile App Tool
10. Finding the Balance Between Reduced Opioid Prescribing and Patient-reported Pain Management Among General Surgery Patients
11. Use of the Electronic Health Record During Clinical Encounters: An Experience Survey
12. Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study
13. Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination Era
14. Employment Characteristics and Risk of Hospitalization Among Older Adults Participating in the Mayo Clinic Biobank
15. Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis
16. Making sense of diabetes medication decisions: a mixed methods cluster randomized trial using a conversation aid intervention
17. Development and Validation of a Kidney-Transplant Specific Measure of Treatment Burden
18. The Quality of Life after Endometrial Cancer Study: Baseline Characteristics and Patient-Reported Outcomes.
19. Olaparib in Patients With Pancreatic Cancer With BRCA1/2 Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
20. Correction to: Making sense of diabetes medication decisions: a mixed methods cluster randomized trial using a conversation aid intervention
21. Improving the Delivery of Function-Directed Care During Acute Hospitalizations: Methods to Develop and Validate the Functional Assessment in Acute Care Multidimensional Computerized Adaptive Test (FAMCAT)
22. Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers
23. Talazoparib in Patients With Solid Tumors With BRCA1 / 2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study.
24. Health Literacy and Outcomes Among Patients With Heart Failure: A Systematic Review and Meta-Analysis
25. Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
26. Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis
27. Clarifying the UDD Tool's Role in Post-Esophagectomy Care
28. Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
29. Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients
30. Preliminary Normative Standards of the Mayo Clinic Esophagectomy CONDUIT Tool
31. Development and Validation of a Symptom-Based Activity Index for Adults With Eosinophilic Esophagitis
32. Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis
33. Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
34. Skin Cancer Risk Perception and Tanning Bed Use: A Population-Based Survey to Identify Persons at Risk for Melanoma in Olmsted County, Minnesota
35. A case‐control survey study of environmental risk factors for primary hypoadrenocorticism in dogs
36. Cancer incidence in the Somali population of Olmsted County: A Rochester epidemiology project study
37. Listening in on difficult conversations: an observational, multi-center investigation of real-time conversations in medical oncology
38. Norming plans for the NIH Toolbox
39. Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)
40. Impact of lymphoma survivorship clinic visit on patient-centered outcomes
41. Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
42. The PROMIS fatigue item bank has good measurement properties in patients with fibromyalgia and severe fatigue
43. Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden
44. Talazoparib (Tala) in patients (pts) with solid tumors with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
45. Item response theory analysis to evaluate reliability and minimal clinically important change of the Roland-Morris Disability Questionnaire in patients with severe disability due to back pain from vertebral compression fractures
46. Talazoparib (Tala) in patients (pts) with colorectal cancer (CRC) with BRCA1/2 mutations (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
47. Patients’ knowledge about the outcomes of thyroid biopsy: a patient survey
48. Supplementary Form 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
49. Supplementary Table 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
50. Achieving a 5-star rating: Analysis of Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores among patients undergoing elective colorectal operations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.